KLF2 is a rate-limiting transcription factor that can be targeted to enhance regulatory T-cell production

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 26, 2014, Pages 9579-9584

  Pabbisetty, Sudheer K ^a   Rabacal, Whitney ^a   Maseda, Damian ^a   Cendron, Delphine ^a   Collins, Patrick L ^b   Hoek, Kristen L ^a   Parekh, Vrajesh V ^a   Aune, Thomas M ^a,b   Sebzda, Eric ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IKAROS TRANSCRIPTION FACTOR; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; KRUPPEL LIKE FACTOR 2; SPHINGOSINE 1 PHOSPHATE RECEPTOR; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ANIMAL EXPERIMENT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL VIABILITY; EX VIVO STUDY; FLOW CYTOMETRY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; AUTOIMMUNITY; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; DNA PRIMERS; FLOW CYTOMETRY; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; T-LYMPHOCYTES, REGULATORY;

EID: 84903704852     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1323493111     Document Type: Article

References (42)

1. Sakaguchi S, Miyara M, Costantino CM, Hafler DA (2010) FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 10(7):490-500.
2. Josefowicz SZ, Lu LF, Rudensky AY (2012) Regulatory T cells: Mechanisms of differentiation and function. Annu Rev Immunol 30:531-564.
3. Haxhinasto S, Mathis D, Benoist C (2008) The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J Exp Med 205(3):565-574.
4. Sauer S, et al. (2008) T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci USA 105(22):7797-7802.
5. Harada Y, et al. (2010) Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells. J Exp Med 207(7):1381-1391.
6. Ma J, Ding Y, Fang X, Wang R, Sun Z (2012) Protein kinase C-θ inhibits inducible regulatory T cell differentiation via an AKT-Foxo1/3a- dependent pathway. J Immunol 188(11):5337-5347.
7. Ouyang W, et al. (2010) Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat Immunol 11(7):618-627.
8. Kerdiles YM, et al. (2010) Foxo transcription factors control regulatory T cell development and function. Immunity 33(6):890-904.
9. Fabre S, et al. (2008) FOXO1 regulates L-Selectin and a network of human T cell homing molecules downstream of phosphatidylinositol 3-kinase. J Immunol 181(5): 2980-2989.
10. Kerdiles YM, et al. (2009) Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. Nat Immunol 10(2):176-184.
11. Waugh C, Sinclair L, Finlay D, Bayascas JR, Cantrell D (2009) Phosphoinositide (3,4,5)-triphosphate binding to phosphoinositide-dependent kinase 1 regulates a protein kinase B/Akt signaling threshold that dictates T-cell migration, not proliferation. Mol Cell Biol 29(21):5952-5962.
12. Bai A, Hu H, Yeung M, Chen J (2007) Kruppel-like factor 2 controls T cell trafficking by activating L-selectin (CD62L) and sphingosine-1-phosphate receptor 1 transcription. J Immunol 178(12):7632-7639.
13. Carlson CM, et al. (2006) Kruppel-like factor 2 regulates thymocyte and T-cell migration. Nature 442(7100):299-302.
14. Sebzda E, Zou Z, Lee JS, Wang T, Kahn ML (2008) Transcription factor KLF2 regulates the migration of naive T cells by restricting chemokine receptor expression patterns. Nat Immunol 9(3):292-300.
15. Liu G, et al. (2009) The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR. Nat Immunol 10(7):769-777.
16. Liu G, Yang K, Burns S, Shrestha S, Chi H (2010) The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H) 1 and T(reg) cells. Nat Immunol 11(11):1047-1056.
17. Hoek KL, et al. (2010) Follicular B cell trafficking within the spleen actively restricts humoral immune responses. Immunity 33(2):254-265.
18. Weinreich MA, et al. (2009) KLF2 transcription-factor deficiency in T cells results in unrestrained cytokine production and upregulation of bystander chemokine receptors. Immunity 31(1):122-130.
19. Dardalhon V, et al. (2008) IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol 9(12): 1347-1355.
20. Sugimoto N, et al. (2006) Foxp3-dependent and-independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis. Int Immunol 18(8):1197-1209.
21. Thornton AM, et al. (2010) Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol 184(7):3433-3441.
22. Gottschalk RA, Corse E, Allison JP (2012) Expression of Helios in peripherally induced Foxp3+ regulatory T cells. J Immunol 188(3):976-980.
23. Zabransky DJ, et al. (2012) Phenotypic and functional properties of Helios+ regulatory T cells. PLoS ONE 7(3):e34547.
24. Weiss JM, et al. (2012) Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. J Exp Med 209(10): 1723-1742, S1.
25. Yadav M, et al. (2012) Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J Exp Med 209(10):1713-1722, S1-S19.
26. Mucida D, et al. (2005) Oral tolerance in the absence of naturally occurring Tregs. J Clin Invest 115(7):1923-1933.
27. Sun CM, et al. (2007) Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 204(8):1775-1785.
28. Josefowicz SZ, et al. (2012) Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 482(7385):395-399.
29. Zheng Y, et al. (2010) Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463(7282):808-812.
30. Wang Z, et al. (2008) Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 40(7):897-903.
31. Sen-Banerjee S, et al. (2005) Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells. Circulation 112(5):720-726.
32. Parmar KM, et al. (2005) Statins exert endothelial atheroprotective effects via the KLF2 transcription factor. J Biol Chem 280(29):26714-26719.
33. Bu DX, et al. (2010) Statin-induced Krüppel-like factor 2 expression in human and mouse T cells reduces inflammatory and pathogenic responses. J Clin Invest 120(6): 1961-1970.
34. Xie P, et al. (2011) Smurf1 ubiquitin ligase targets Kruppel-like factor KLF2 for ubiquitination and degradation in human lung cancer H1299 cells. Biochem Biophys Res Commun 407(1):254-259.
35. Wang R, et al. (2013) FBW7 regulates endothelial functions by targeting KLF2 for ubiquitination and degradation. Cell Res 23(6):803-819.
36. Zhang X, Srinivasan SV, Lingrel JB (2004) WWP1-dependent ubiquitination and degradation of the lung Krüppel-like factor, KLF2. Biochem Biophys Res Commun 316(1):139-148.
37. Lio CW, Hsieh CS (2011) Becoming self-aware: The thymic education of regulatory T cells. Curr Opin Immunol 23(2):213-219.
38. Xiong Y, et al. (2012) Polycomb antagonizes p300/CREB-binding protein-associated factor to silence FOXP3 in a Kruppel-like factor-dependent manner. J Biol Chem 287(41):34372-34385.
39. Khattri S, Zandman-Goddard G (2013) Statins and autoimmunity. Immunol Res 56(2-3):348-357.
40. Lee JS, et al. (2006) Klf2 is an essential regulator of vascular hemodynamic forces in vivo. Dev Cell 11(6):845-857.
41. Yamashita M, et al. (2005) Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation. Cell 121(1):101-113.
42. Ruzankina Y, et al. (2007) Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. Cell Stem Cell 1(1): 113-126.